MedWatch

Costco contract unlikely to be renewed, Sonova hints

In October, the US retail chain reportedly stopped selling a private label hearing aid launched by Sonova. The hearing company now says it stands to lose a ”large contract” in the US.

Photo: Jim Young/Reuters/Ritzau Scanpix

Based on a single line in Sonova’s recently published half-year report for 2022/2023, it seems likely that the world’s largest hearing aid manufacturer is about to lose its large US-based customer, Costco.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Bank believes in cancer approval for Genmab

In Jyske Bank’s eyes, Genmab’s newest cancer candidate is almost certain to be approved, though the bank says stock increases in the past year have reduced the upside potential for the Danish biotech firm.

Further reading

Related articles

Latest news

See all jobs